ASCO 2022 Conference Coverage


 

Lecture Summary - ASCO 2022 on Alpelisib + Continued ET Following Progression on ET in HR+/HER2-/PIK3CAm mBC: A Big Ten Cancer Research Consortium Study

65 views
June 10, 2022
Comments 0
Login to view comments. Click here to Login